The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Abiomed Inc

Nasdaq: ABMD
Last

(U.S.) $37.09

Today's change+0.17 +0.46%
Updated December 18 2:36 PM EST. Delayed by at least 15 minutes.
 

Abiomed Inc

Nasdaq: ABMD
Last

(U.S.) $37.09

Today's change+0.17 +0.46%
Updated December 18 2:36 PM EST. Delayed by at least 15 minutes.

Abiomed Inc up (U.S.)$0.17

Abiomed Inc is up today by (U.S.)$0.17 or 0.46% to (U.S.)$37.09. Over the last five days, shares have gained 0.49% and are currently 2.19% off of the 52-week high. Shares have outperformed the S&P 500 by 22.94% during the last year.

Key company metrics

  • Open(U.S.) $37.39
  • Previous close(U.S.) $36.92
  • High(U.S.) $37.76
  • Low(U.S.) $36.80
  • Bid / Ask(U.S.) $37.05 / (U.S.) $37.09
  • YTD % change+38.71%
  • Volume206,980
  • Average volume (10-day)402,261
  • Average volume (1-month)385,193
  • Average volume (3-month)357,242
  • 52-week range(U.S.) $20.29 to (U.S.) $37.92
  • Beta1.76
  • Trailing P/E155.33×
  • P/E 1 year forward227.62×
  • Forward PEG10.59×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.24
Updated December 18 2:36 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+5.14%

Based on its net profit margin of 5.14%, Abiomed Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.36%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue52495046
Total other revenue--------
Total revenue52495046
Gross profit42394037
Total cost of revenue1010109
Total operating expense48504742
Selling / general / administrative29322924
Research & development9988
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income4-245
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax4-145
Income after tax4-244
Income tax, total0000
Net income4-244
Total adjustments to net income--------
Net income before extra. items4-244
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items4-244
Inc. avail. to common incl. extra. items4-244
Diluted net income4-244
Dilution adjustment--000
Diluted weighted average shares42404242
Diluted EPS excluding extraordinary itemsvalue per share0.09-0.040.090.11
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.09-0.040.090.11